These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Role of Androgen Receptor in Prostate Cancer: A Review. Fujita K; Nonomura N World J Mens Health; 2019 Sep; 37(3):288-295. PubMed ID: 30209899 [TBL] [Abstract][Full Text] [Related]
9. To die or to survive, a fatal question for the destiny of prostate cancer cells after androgen deprivation therapy. Zhang KX; Firus J; Prieur B; Jia W; Rennie PS Cancers (Basel); 2011 Mar; 3(2):1498-512. PubMed ID: 24212771 [TBL] [Abstract][Full Text] [Related]
10. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways. Vis AN; Schröder FH BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559 [TBL] [Abstract][Full Text] [Related]
11. Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges. Kita Y; Goto T; Akamatsu S; Yamasaki T; Inoue T; Ogawa O; Kobayashi T Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30248934 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor: what we know and what we expect in castration-resistant prostate cancer. Cai Z; Chen W; Zhang J; Li H Int Urol Nephrol; 2018 Oct; 50(10):1753-1764. PubMed ID: 30128923 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance in castration-resistant prostate cancer (CRPC). Chandrasekar T; Yang JC; Gao AC; Evans CP Transl Androl Urol; 2015 Jun; 4(3):365-80. PubMed ID: 26814148 [TBL] [Abstract][Full Text] [Related]
14. Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer. Dalal K; Ban F; Li H; Morin H; Roshan-Moniri M; Tam KJ; Shepherd A; Sharma A; Peacock J; Carlson ML; LeBlanc E; Perez C; Duong F; Ong CJ; Rennie PS; Cherkasov A Cancer Lett; 2018 Nov; 437():35-43. PubMed ID: 30165195 [TBL] [Abstract][Full Text] [Related]
15. Molecular model for neuroendocrine prostate cancer progression. Chen R; Dong X; Gleave M BJU Int; 2018 Oct; 122(4):560-570. PubMed ID: 29569310 [TBL] [Abstract][Full Text] [Related]
16. Androgen receptor as a target in androgen-independent prostate cancer. Balk SP Urology; 2002 Sep; 60(3 Suppl 1):132-8; discussion 138-9. PubMed ID: 12231070 [TBL] [Abstract][Full Text] [Related]
17. The role of the androgen receptor in the development and progression of prostate cancer. Jenster G Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183 [TBL] [Abstract][Full Text] [Related]